Disc Medicine (IRON) PT Raised to $153 at Cantor Fitzgerald After FDA Priority Voucher Win
Tweet Send to a Friend
Cantor Fitzgerald analyst Kristen Kluska raised the price target on Disc Medicine (NASDAQ: IRON) to $153.00 (from $132.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
